OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	26
Unusual Forms of Pulmonary Hypertension	23
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	22
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy	21
When all Else Fails, Try This	20
Forthcoming Issues	19
Changing Landscape of Heart Failure Imaging	18
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	17
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	15
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias	14
Therapy-Related Clonal Hematopoiesis	13
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction	13
Contributors	13
Mitral Regurgitation	12
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	12
Contributors	12
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	11
Preload Reduction Therapies in Heart Failure	11
Genetics of High-Altitude Pulmonary Edema	11
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	10
Arrhythmias in Adult Congenital Heart Disease Heart Failure	10
Contributors	10
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications	10
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	9
Heart Failure Clinics	9

Coronary Angiography in the Evaluation of Systolic Heart Failure	9
Copyright	9
What Is New in Risk Assessment in Nuclear Cardiology?	8
Contributors	8
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	8
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	8
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	7
Hypertrophic Cardiomyopathy	7
Guide to Temporary Mechanical Support in Cardiogenic Shock	7
Arrythmia-Mediated Valvular Heart Disease	7
Myocardial Dysfunction in Patients with Cancer	7
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	7
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	6
Cardiac Amyloidosis	6
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	6
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	6
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	6
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear	6
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	6
SGLT2 Inhibitors in Heart Failure	6
Noncoding RNAs in Pulmonary Arterial Hypertension	6
Cardiac Contractility Modulation	6
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	6
Preface	5
Contributors	5
Contents	5
Contents	5
Copyright	4
Epigenetics of Heart Failure	4
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	4
Aortic Valvular Stenosis and Heart Failure	4
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	4
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	4
Contents	4
Adults with Congenital Heart Disease and Transplant	4
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	4
Evolving Strategies in Cardiac Amyloidosis	4
Copyright	4
Contents	4
Contributors	3
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	3
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	3
Remote Monitoring Devices and Heart Failure	3
Advances in the Therapy of Light Chain Cardiac Amyloidosis	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Contents	3
SGLT2 Inhibitors and Peripheral Vascular Events	3
Coronary Microvascular Dysfunction	3
Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Exercise Testing in Pulmonary Hypertension and Heart Failure	3

Contents	3
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	3
Clinical Practice Guidelines in Cardio-Oncology	3